Risk Factors, Comorbidities, and Clinical Profile of Intracerebral Haemorrhagic Stroke: A Hospital-Based Study in Tripura
DOI:
https://doi.org/10.68716/IJAMSR.2026.1203Keywords:
Intracerebral haemorrhage; Stroke; Hypertension; Obesity; Lifestyle risk factors; Comorbidities; Tripura; IndiaAbstract
Background: Intracerebral haemorrhage (ICH) is a devastating subtype of stroke with high mortality and disability, particularly in low‑resource regions such as North‑East India. Despite advances in neurocritical care, outcomes remain poor, and regional data are limited.
Objective: To evaluate the demographic profile, lifestyle risk factors, comorbidities, and clinical examination findings of patients with ICH admitted to a tertiary care hospital in Tripura.
Methods: A hospital‑based cross‑sectional study was conducted over 18 months at Agartala Government Medical College and G.B. Pant Hospital. A total of 432 patients with radiologically confirmed ICH were enrolled. Data on demographics, lifestyle behaviours, body mass index (BMI), comorbidities, and clinical examination findings were systematically recorded and analysed using descriptive statistics.
Results: The mean age of patients was 58.5 ± 15.0 years, with a male predominance (60.6%). Lifestyle risk behaviours were common, with smoking (54.2%), tobacco chewing (53.7%), and alcohol consumption (39.1%) reported. Obesity (45.9%) and overweight (29.9%) were highly prevalent. Hypertension (88.9%), dyslipidemia (80.6%), and diabetes mellitus (59.3%) were the most frequent comorbidities. Clinical examination revealed cardiomegaly in 87.5% of patients, with mean systolic and diastolic blood pressures of 184.6 ± 28.0 mmHg and 108.5 ± 16.2 mmHg, respectively. Anaemia (48.6%) and thrombocytopenia (34.7%) were also common.
Conclusion: The findings highlight the clustering of modifiable lifestyle behaviours, obesity, and vascular comorbidities as major determinants of ICH in Tripura. Strengthening community‑level hypertension control, lifestyle modification, and hospital‑based acute care bundles may reduce the burden of haemorrhagic stroke in resource‑constrained settings.
Downloads
References
1. Agboyibor K, Ghamari SH, Tye SC, Schiess N, Dua T, Pandian JD, et al. First World Health Organization resolution on stroke at the Seventy-ninth World Health Assembly: A turning point for global stroke prevention, care, and health-system readiness. Int J Stroke. 2026;21(6):735 41. doi:10.1177/17474930261452532.
2. An SJ, Kim TJ, Yoon BW. Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. J Stroke. 2017;19(1):3-10. doi: 10.5853/jos.2016.00864.
3. Poon MT, Fonville AF, Al-Shahi Salman R. Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2014;85(6):660-7. doi: 10.1136/jnnp-2013-306476.
4. Wang S, Zou XL, Wu LX, Zhou HF, Xiao L, Yao T, et al. Epidemiology of intracerebral hemorrhage: A systematic review and meta-analysis. Front Neurol. 2022;13:915813. doi: 10.3389/fneur.2022.915813.
5. Krishnamurthi RV, Ikeda T, Feigin VL. Global, Regional and Country-Specific Burden of Ischaemic Stroke, Intracerebral Haemorrhage and Subarachnoid Haemorrhage: A Systematic Analysis of the Global Burden of Disease Study 2017. Neuroepidemiology. 2020;54(2):171-9. doi: 10.1159/000506396.
6. Pandian JD, Sudhan P. Stroke epidemiology and stroke care services in India. J Stroke. 2013;15(3):128-34. doi: 10.5853/jos.2013.15.3.128.
7. Cinza-Sanjurjo S, González-Juanatey JR. High blood pressure and intracerebral haemorrhage: a recognized risk factor with new knowledge. Eur J Prev Cardiol. 2024;31(14):1711-2. doi: 10.1093/eurjpc/zwae187.
8. Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012;11(8):720-31. doi: 10.1016/S1474-4422(12)70104-7.
9. Flaherty ML, Woo D, Haverbusch M, Sekar P, Khoury J, Sauerbeck L, et al. Racial variations in location and risk of intracerebral hemorrhage. Stroke. 2005;36(5):934-7. doi: 10.1161/01.STR.0000160756.72109.95.
10. Li L, Poon MTC, Samarasekera NE, Perry LA, Moullaali TJ, Rodrigues MA, et al. Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies. Lancet Neurol. 2021;20(6):437-47. doi: 10.1016/S1474-4422(21)00075-2.
11. Wolsink A, Cliteur MP, van Asch CJ, Boogaarts HD, Dammers R, Hannink G, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage, according to age, sex, and country income level: a systematic review and meta-analysis. Lancet Reg Health Eur. 2024;49:101180. doi: 10.1016/j.lanepe.2024.101180.
12. Zhang Y, Tuomilehto J, Jousilahti P, Wang Y, Antikainen R, Hu G. Lifestyle factors on the risks of ischemic and hemorrhagic stroke. Arch Intern Med. 2011;171(20):1811-8. doi: 10.1001/archinternmed.2011.443.
13. Phukan RK, Ali MS, Chetia CK, Mahanta J. Betel nut and tobacco chewing; potential risk factors of cancer of oesophagus in Assam, India. Br J Cancer. 2001;85(5):661-7. doi: 10.1054/bjoc.2001.1920.
14. Das SK, Banerjee TK, Biswas A, Roy T, Raut DK, Mukherjee CS, et al. A prospective community-based study of stroke in Kolkata, India. Stroke. 2007;38(3):906-10. doi: 10.1161/01.STR.0000258111.00319.58.
15. Sah NKP, Rathi H, Gangwar S, Tiwari R, Pal D. Epidemiological Profile and Risk Factors of Stroke in a Tertiary Care Hospital: A Cross-Sectional Study. Cureus. 2025;17(10):e94241. doi: 10.7759/cureus.94241.
16. Feigin VL, Norrving B, Mensah GA. Global Burden of Stroke. Circ Res. 2017;120(3):439-48. doi: 10.1161/CIRCRESAHA.116.308413.
17. Narayan SK, Sivaprasad P, Sushma S, Sahoo RK, Dutta TK. Etiology and outcome determinants of intracerebral hemorrhage in a south Indian population, A hospital-based study. Ann Indian Acad Neurol. 2012;15(4):263-6. doi: 10.4103/0972-2327.104333.
18. International Institute for Population Sciences (IIPS) and ICF. National Family Health Survey (NFHS 5), India, 2019–21: Tripura. Mumbai: IIPS; 2021. Available from: https://dhsprogram.com/pubs/pdf/FR374/FR374_Tripura.pdf
19. O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761-75. doi: 10.1016/S0140-6736(16)30506-2.
20. Becerril-Gaitan A, Ding D, Ironside N, Southerland AM, Worrall BB, Testai FD, et al. Association Between Body Mass Index and Functional Outcomes in Patients With Intracerebral Hemorrhage. Neurology. 2024;102(2):e208014. doi: 10.1212/WNL.0000000000208014.
21. Dave N, Vora A, Jani P. Clinical Profiles and Predictors of Mortality in Intracerebral Hemorrhage: A Prospective Cohort Study From Western India. Cureus. 2025;17(9):e93287. doi: 10.7759/cureus.93287.
22. Misra S, Kawamura Y, Singh P, Sengupta S, Nath M, Rahman Z, et al. Prognostic biomarkers of intracerebral hemorrhage identified using targeted proteomics and machine learning algorithms. PLoS One. 2024;19(6):e0296616. doi: 10.1371/journal.pone.0296616.
23. Anderson CS, Selim MH, Molina CA, Qureshi AI. Intensive Blood Pressure Lowering in Intracerebral Hemorrhage. Stroke. 2017;48(7):2034-7. doi: 10.1161/STROKEAHA.117.016185.
24. Hanley DF, Thompson RE, Rosenblum M, Yenokyan G, Lane K, McBee N, et al. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019;393(10175):1021-32. doi: 10.1016/S0140-6736(19)30195-3.
25. Connolly SJ, Milling TJ Jr, Eikelboom JW, Gibson CM, Curnutte JT, Gold A, et al. Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors. N Engl J Med. 2016;375(12):1131-41. doi: 10.1056/NEJMoa1607887.
26. Parry-Jones AR, Järhult SJ, Kreitzer N, Morotti A, Toni D, Seiffge D, et al. Acute care bundles should be used for patients with intracerebral haemorrhage: An expert consensus statement. Eur Stroke J. 2024;9(2):295-302. doi: 10.1177/23969873231220235.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in the International Journal of Advanced Medical and Scientific Research (IJAMSR) are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author(s) and the journal are properly credited. Authors retain copyright of their work while granting IJAMSR the right of first publication.
https://creativecommons.org/licenses/by/4.0/
